| 靶点: |
Ki: 0.17 nM (Human BB1 receptor), 0.66 nM (Rat BB1 receptor), 1 nM (Human BB2 receptor), 16 nM (Rat BB2 receptor);EC50: 0.31 μM (FPR1), 0.66 μM (FPR2) |
| 体内研究: |
PD176252 (1,10 μg,po) 有效抑制裸鼠体内 NCI-H1299 异种移植物的增殖生长。 |
| 参考文献: |
1. Ashwood V, et al. PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. Bioorg Med Chem Lett. 1998 Sep 22;8(18):2589-94. 2. Schepetkin IA, et al. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors. Mol Pharmacol. 2011 Jan;79(1):77-90. 3. Moody TW, et al. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells. Eur J Pharmacol. 2003 Aug 1;474(1):21-9. |
| 保存条件: |
RT |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.71 ml |
8.552 ml |
17.104 ml |
| 5 mM |
0.342 ml |
1.71 ml |
3.421 ml |
| 10 mM |
0.171 ml |
0.855 ml |
1.71 ml |
| 50 mM |
0.034 ml |
0.171 ml |
0.342 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |